31 May 2016

Corbett Keeling advises on the Management Buy-Out of SEP, a speciality pharmaceutical and medical devices group

Corbett Keeling is pleased to announce that the management team of Speciality European Pharma Limited (“SEP” or “the Company”), has acquired the Company from its venture capital shareholders, with the backing of Juno Pharmaceuticals Inc. (“Juno”), an international speciality pharmaceutical company and leading life science investor.

Read More
24 May 2016

Corbett Keeling stands behind its employees and their lives outside work

Read More
17 May 2016

Private equity investors still have plenty of funds to deploy on businesses with compelling stories to tell

The latest edition of UK Private Company Director, the newsletter for directors of owner-managed and private equity backed businesses, reports:

Read More